Persico, M <br/><br/>
Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C.  [electronic resource] 

 -  Gut  Apr 2008 
 - 507-15 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-3288 
<br/><br/><label>Standard No.: </label>10.1136/gut.2007.129478  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antiviral Agents--therapeutic use<br/>Biomarkers--blood<br/>Cell Line, Transformed<br/>Drug Therapy, Combination<br/>Female<br/>Gene Expression Profiling--methods<br/>Genetic Markers<br/>Haplotypes<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Interferon-alpha--therapeutic use<br/>Male<br/>Middle Aged<br/>Polymorphism, Single Nucleotide<br/>Prognosis<br/>RNA, Messenger--genetics<br/>Ribavirin--therapeutic use<br/>Suppressor of Cytokine Signaling 3 Protein<br/>Suppressor of Cytokine Signaling Proteins--blood<br/>Treatment Failure<br/>Treatment Outcome